-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical network August 3, low-value consumables also included in the centralized volume of procurement infusion, disposable syringe July 31, Taiyuan City Medical Insurance Management Service Center issued "Taiyuan - Jinzhong - Zhangzhou medical medical equipment centralized volume procurement project results publicity", Shanxi Province International Tender Co., Ltd. by Taiyuan - Jinzhong - Zhangzhou medical institutions drug supplies with the purchase of supplies union commissioned, Taiyuan - Jinzhong - Zhangzhou medical equipment procurement project.
the project on July 30, 2020 in accordance with the prescribed procedures organized negotiations and review, has now completed the review work.
according to the negotiating team evaluation opinions, and confirmed by the purchaser, the relevant transaction results will be announced as follows: Results 1: ordinary infusion Shandong Weigao Group Medical Polymer Products Co., Ltd. Jiangxi Hongda Medical Devices Co., Ltd. Henan Shuguanghui Zhikang Biotech Co., Ltd. Jiangxi Yikang Medical DeviceS Co., Ltd. Jiangsu Suyun Medical Equipment Co., Ltd. Shanghai Zhengbang Medical Technology Co., Ltd. Shandong Weigao Group Medical Polymer Products Co., Ltd. Jiangxi Hongda Medical DeviceS Group Co., Ltd. Jiangxi Yikang Medical DeviceS Group Co., Ltd. Henan Shuguanghui Zhikang Biotech Co., Ltd. Jiangsu Suyun Medical Equipment Co., Ltd. Shanghai Zhengbang Medical Equipment Co., Ltd. Shandong Xinhua Ande Medical Supplies Co., Ltd. low-value supplies into the volume of high-value supplies has been the focus of the volume of procurement, and low-value supplies will also be re-priced.
at the end of March this year, Liaoning Province drug and medical supplies centralized procurement network released the "Liaoyang City, Yingkou City 2020 medical supplies centralized procurement announcement", this centralized procurement and other cities collection is different, the two cities of all public medical institutions using high-value supplies and low-value consumables will be included in the scope.
currently a number of concentrated procurement, are linked to the quantity price, as a bargaining chip to negotiate with enterprises.
in the bargaining process, the purchased varieties and the unpurchased varieties, the provisions are different.
(screenshot source: health insurance bureau documents) specificpoint, the document pointed out that for the supplies used by the hospital before the need not be declared, directly into the bargaining link to negotiate price reduction;
but because there is no price reference in price, so do not participate in bargaining, must accept the lowest price of the same variety, before being selected.
less, will be eliminated the size of the decline, related to whether the finalists.
procurement program pointed out that Liaoyang City infusion belt volume bargaining price of selected products and the same variety of infusion products quoted higher than the price of 30% of the direct elimination.
for example, an infusion in Liaoyang City in 2019 fell from 14 yuan to 2.5 yuan, a decrease of 82%.
if 2.5 yuan is the winning base price, on the basis of 2.5 yuan, the price of new products up to 30%, that is, up to 3.25 yuan. if the
is higher than 3.25 yuan, it will be eliminated directly.
to this, Liaoyang City Health Insurance Bureau tips: whether to enter the shortlist, does not depend on the price reduction of individual varieties, but depends on the same group of similar varieties of the price reduction.
(screenshot source: Health Insurance Bureau file) thus shows that enterprises need to compress supplies moisture, in order to be eligible for the final.
the price of the decline, how to ensure the basic profits of dealers? The head of the health insurance bureau to the Cypress blue device said that the price hook is basic, hope to get low prices to patients affordable.
but if the product decline did not meet the requirements, but after expert advice, the price of the product has dropped to freezing point, dealers have been very small profits, will still be selected.
.